Gustav
marketing
CDBIO
Norway
Biography
Vaccibody in August 2015. He holds a PhD in Immunochemical Techniques and a MSc in Chemical Engineering from the Technical University of Denmark as well as a B.Com. in International Economy from Copenhagen Business School. Martin started his career in Dako AS, followed by Ostemeter AS (CEO), Torsana Biosensor AS (CEO), Celtor Biosystems Inc (EVP), Combio AS (CEO), Natimmune AS (CEO), Aros Pharma ApS (CEO) and most recently Epitherapeutics Aps now sold to Gilead (CEO).
Research Interest
His experience includes a significant number of transactions within business development, trade sales, mergers & acquisitions as well as management of research and development.
